Abgent

Abgent, a WuXi AppTec company, is a leading manufacturer of primary antibodies based in San Diego, California. The company employs 23 people and generates $32.5 million in annual revenue. Abgent specializes in providing high-quality primary antibodies to researchers and companies in the life sciences industry. They produce over 1,000 new antibodies annually, focusing on areas like autophagy, stem cells, and neurodegeneration. Abgent's portfolio includes a "Crown" line of premium antibodies and offers evaluation size vials for more than 10,000 products. In addition to antibodies, Abgent provides custom antibody development, custom peptide synthesis, and custom protein expression services. Notably, they excel in synthesizing complex peptides, including long peptides. A key differentiator for Abgent is its commitment to producing most antibodies in-house, ensuring high specificity, affinity, and reproducibility. They are dedicated to achieving proteome-wide antibody coverage and providing excellent customer support through a comprehensive website and easy ordering process. Abgent also guarantees high quality, rapid turnaround times, and personalized support for all its services. To learn more about Abgent and its products and services, visit their website at abgent.com or reach out to their team directly.